Skip to Content
Center for International Blood and Marrow Transplant Research

CK12-02b

Main Content

A retrospective assessment of outcomes of patients who have undergone allogeneic stem cell transplant for chronic lymphocytic leukemia based on histocompatibility leukocyte antigen type.

Study #: CK12-02b

Study Status: Published

Presentation(s)

2016, ASH (Poster)

Assessment of impact of HLA type on outcomes of allogeneic hematopoietic stem cell transplantation for chronic lymphocytic leukemia.

Citation

Hill BT, Ahn KW, Hu Z-H, Aljurf M, Beitinjaneh A, Cahn J-Y, Cerny J, Kharfan-Dabaja MA, Ganguly S, Ghosh N, Grunwald MR, Inamoto Y, Kindwall-Keller T, Nishihori T, Olsson RF, Saad A, Seftel M, Seo S, Szer J, Tallman M, Ustun C, Wiernik PH, Maziarz RT, Kalaycio M, Alyea E, Popat U, Sobecks R, Saber W.

Biology of Blood and Marrow Transplantation: Journal of the American Society for Blood and Marrow Transplantation. 2018, Mar 01: 24(3): 24(3):581-586. doi: 10.1016/j.bbmt.2017.10.015. Epub 2017, Oct 12. PMCID:PMC5944847.

PubMed

PMID: 29032274

Abstract